MARTINGALE ASSET MANAGEMENT L P

Position in MYGN — Myriad Genetics Inc

CIK 936944 BOSTON, MA

Position in MYGN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$744,421

-$48,375 QoQ

Shares Held

165,427

+28.3% QoQ

Ownership

0.175%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 11% Shared 0% None 89%

Healthcare · as of Mar 31, 2026

MARTINGALE ASSET MANAGEMENT L P holds $5,432,694 across 5 Diagnostics & Research names. MYGN ranks #4 (13.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	3,915	$1,924,339
2	DHR	Danaher Corp /De/	6,186	$1,172,865
3	MEDP	Medpace Holdings, Inc.	1,933	$928,207
4	MYGN	Myriad Genetics Inc This page	165,427	$744,421
5	QGEN	Qiagen N.V.	16,555	$662,862

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$744,421	165,427	+28.3%	Shares	Sole	2026-05-13
2025-12-31	$792,796	128,910	+74.1%	Shares	Sole	2026-02-13
2025-09-30	$535,193	74,024	—	Shares	Sole	2025-11-13
No filing history on record for this holder in this stock.